kohdelääkkeet
Kohdelääkkeet, also known as targeted therapies, represent a class of drugs designed to specifically attack cancer cells by interfering with molecules that are crucial for cancer growth, progression, and spread. Unlike traditional chemotherapy, which affects all rapidly dividing cells, both healthy and cancerous, kohdelääkkeet are engineered to identify and target specific characteristics of cancer cells, such as particular proteins or genetic mutations. This precision aims to minimize damage to normal tissues, potentially leading to fewer side effects and improved treatment efficacy.
The development of kohdelääkkeet has been a significant advancement in cancer treatment. These drugs can work
Kohdelääkkeet are used in the treatment of a wide range of cancers, including certain types of breast